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Background: Various hospital accreditation and quality assurance entities in the United States have approved and
endorsed performance measures promoting alcohol brief intervention (BI) for hospitalized individuals who screen
positive for unhealthy alcohol use, the spectrum of use ranging from hazardous use to alcohol use disorders. These
performance measures have been controversial due to the limited and equivocal evidence for the efficacy of BI
among hospitalized individuals. The few BI trials conducted with hospital inpatients vary widely in methodological
quality. While the majority of these studies indicate limited to no effects of BI in this population, none have been
designed to account for the most pervasive methodological issue in BI studies presumed to drive study findings
towards the null: assessment reactivity (AR).
Methods/Design: This is a three-arm, single-site, randomized controlled trial of BI for hospitalized patients at a large
academic medical center affiliated with the U.S. Department of Veterans Affairs who use alcohol at hazardous levels
but do not have an alcohol use disorder. Participants are randomized to one of three study conditions. Study Arm 1
receives a three-part alcohol BI. Study Arm 2 receives attention control. To account for potential AR, Study Arm 3
receives AC with limited assessment. Primary outcomes will include the number of standard drinks/week and binge
drinking episodes reported in the 30-day period prior to a final measurement visit obtained 6 months after hospital
discharge. Additional outcomes will include readiness to change drinking behavior and number of adverse
consequences of alcohol use. To assess differences in primary outcomes across the three arms, we will use
mixed-effects regression models that account for a patient’s repeated measures over the timepoints and clustering
within medical units. Intervention implementation will be assessed by: a) review of intervention audio recordings to
characterize barriers to intervention fidelity; and b) feasibility of participant recruitment, enrollment, and follow-up.
Discussion: The results of this methodologically rigorous trial will provide greater justification for or against the use of
BI performance measures in the inpatient setting and inform organizational responses to BI-related hospital accreditation
and performance measures.
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Unhealthy alcohol use comprises the spectrum of alcohol
use, ranging from hazardous drinking, (defined as con-
sumption that exceeds 14 standard drinks per week or
4 per occasion for men, and 7 standard drinks per week
or 3 per occasion for women and healthy individuals
age 65 or older) to alcohol use disorders [1-3]. In 2008,
The Joint Commission (TJC), a hospital accreditation
body in the United States, began the development and
testing of a set of standardized hospital performance
measures to address the entire spectrum of alcohol use
through screening, brief intervention (BI) counseling,
referral to specialty treatment, pharmacotherapy, and
follow-up for hospitalized patients [4]. Because the
measures are designed to be applicable to all hospitalized
patients, regardless of reason for admission, they are cate-
gorized as global performance measures. The measures
are not mandatory, but in January 2012, they began being
offered as one of the sets that hospitals could select to
achieve in order to receive ongoing accreditation [5]. In
February 2014, the measures were endorsed by the U.S.
National Quality Forum [6]. However, during their initial
development and release, the measures generated con-
siderable debate [7-11]. Opponents of the measures
expressed concerns regarding the limited and equivocal
nature of the evidence for efficacy of BI among hospi-
talized individuals. [7,8,12,13]. Meanwhile, proponents
of the measures endorsed their uptake and implemen-
tation, challenging the need for continued alcohol BI
trials across different health-care settings for patients
with varying levels of alcohol involvement and for dif-
ferent combinations of substances [11].
At the time of this debate, few trials of alcohol BI had
even been conducted in hospitalized patients [12,14-16],
with only one of these conducted in a sample of U.S.
drinkers [12]. Because cultural norms and attitudes
about alcohol use vary internationally, caution must be
exercised in generalizing the results of BI trials from
outside the United States. Additionally, while the meth-
odological quality of these BI studies varies widely, the
majority did not demonstrate significant reductions in
alcohol consumption or in the adverse consequences of
alcohol use [12,14,16]. Subsequent post-hoc analyses,
however, suggested that BI was in fact efficacious for
decreasing alcohol consumption at 3 months among
nondependent, hazardous drinkers (i.e., patients whose
use met criteria for hazardous drinking but did not
simultaneously meet criteria for alcohol dependence)
[13]. Additionally, patients consuming alcohol at nonde-
pendent, hazardous levels who had an alcohol-attributable
admitting diagnosis had significantly fewer heavy episodic
(binge) drinking days at 3-month follow-up [17].
Since this active debate, three additional trials of BI for
hospitalized patients have been conducted outside theUnited States, but again, with equivocal results and/or
coarser outcomes, such as change in alcohol screening
status, as opposed to more specific measures of alcohol
consumption [18-20]. BI researchers have long suggested
that null or inconsistent findings in their trials are attrib-
utable to the fact that control groups in these studies
regularly showed decreased alcohol consumption, thus
reducing the ability to demonstrate BI’s effects [21,22].
Furthermore, these reductions in control group drinking
have consistently been explained by assessment reactivity
(AR)—the potential for extensive and/or repeated study
assessments of alcohol use to mimic the components of
alcohol BI. When AR occurs, study results can be biased
towards the null because in essence, both study groups in-
advertently receive some degree of intervention [21-23].
Despite the frequency with which BI investigators ascribe
null findings to AR, few researchers have designed
BI trials to take its potential effects into account
[21,24-26], and none have sought to do so in trials
of hospitalized individuals.
Our overarching goal is to inform the debate about
the efficacy of alcohol BI for hospitalized individuals in a
methodologically rigorous trial using a U.S.-based
sample of hazardous drinkers. Furthermore, our study
design addresses several key methodological issues
that have been raised as concerns regarding other BI
trials. To address (or avoid) AR, we employ a three-
arm randomized design: Arm 1 consists of veterans
randomized to BI (BI); Arm 2 consists of veterans ran-
domized to Attention Control (AC); and Arm 3 con-
sists of veterans randomized to an AC group with
limited assessment (AC-LA) (i.e., alcohol consumption
variables only).Specific aims and hypotheses
The Specific Aims of this three-arm randomized con-
trolled trial (RCT) are to: (1) determine the impact of BI
on the alcohol screening status, number of drinks/week,
number of binge drinking episodes, readiness to change
drinking behavior, and adverse consequences of alcohol
use in hospitalized hazardous drinkers; and (2) evaluate
the process of intervention implementation by character-
izing barriers to intervention fidelity and assessing the
feasibility of recruitment, enrollment, and follow-up of
hospitalized hazardous drinkers.
We hypothesize that at 6 months post-discharge, Arm
1 (BI) will report greater reductions in the alcohol con-
sumption outcomes than Arms 2 (AC) and 3 (AC-LA).
Furthermore, we hypothesize that AR will result in
some reductions in alcohol consumption in Arm 2,
and that the reductions in Arm 2 will be greater than
those displayed in Arm 3, but less than those displayed
by Arm 1.
Broyles et al. Addiction Science & Clinical Practice  (2015) 10:13 Page 3 of 11Methods
Human subjects protections
This study is approved by the Research and Development
Service and the Institutional Review Board (IRB) of the
U.S. Department of Veterans Affairs (VA) Pittsburgh
Healthcare System (VAPHS).Design
This study is a three-arm, single-site, RCT of BI for hospi-
talized, hazardous drinkers. Participants are randomized
to one of three study conditions: Arm 1: a group receiving
a 3-part alcohol BI; Arm 2: an AC group; and Arm 3: an
AC-LA group.Setting and participants
This study is being conducted on the three medical-
surgical (Med-Surg) units at the University Drive cam-
pus of the VAPHS, a large academic medical center in
southwestern Pennsylvania that is part of the VA. The
University Drive campus is home to a 146-bed hospital
facility that provides routine medical, neurological,
psychiatric, and surgical care in addition to specialized
services. Patient and unit characteristics for the three
participating Med-Surg units are provided in Table 1.
Patient inclusion criteria for the study are: admission
to a participating unit; age 21 or older; and hazardous,
nondependent alcohol consumption (defined in Screening
section below). Study exclusion criteria are: participation in
alcohol treatment and/or 12-step programs in the previous
6 months; current drug or alcohol dependence; significant
cognitive impairment; diagnosis of a bipolar or psychotic
disorder; residence in a restricted housing setting (e.g.,
skilled nursing facility); lack of telephone access or unwill-
ingness to be contacted for follow-up; sensory impairment
precluding communication; and medically-related inability
to participate or consent to study participation.Table 1 Medical-surgical unit and patient profile, VAPHS,
FY 2010
Parameter type of unit total for 3 units
Medical Surgical Total
Admissions/month 407 240 647
Average daily census 67 49 58
Average length of stay (days) Unit A Unit B Unit C
3.9(Surg) (Med-Tele) (Med-Liver)
3.6 3.1 5.0
Female veterans (%) 4
OEF/OIF veterans (%) 2
Average patient age 65
% Age 50 or under 10
Note: Med =Medical; Liver = Liver Transplant; Surg = Surgical; Tele = Telemetry;
VAPHS = VA Pittsburgh Healthcare System.Recruitment, screening, and enrollment
In the inpatient care setting, the logistics of screening
and recruitment of hospitalized patients for research
study participation require careful consideration. Adher-
ence to federal and local human subjects protections for
research can be challenged by patient acuity, inpatient
processes of care (e.g., medication administration/side
effects, bedside and off-unit procedures), and the need
for countless assessments by professionals from multiple
disciplines and sub-specialties. Our multi-step proce-
dures for prescreening, approach, screening, informed
consent, and study enrollment are described below and
depicted in Figure 1.
Prescreening
Because of the high volume of admissions to the partici-
pating units (approximately 650 admissions each month),
we have a Waiver of Informed Consent from the IRB at
VAPHS that authorizes us to generate a daily list of pa-
tients admitted to the participating units and allows for
review of each admitted patient’s electronic medical
record (EMR) in order to identify ineligibility criteria
(e.g., housing status, psychiatric diagnosis). This pre-
screening process allows us to avoid exerting unnecessary
burden on acutely ill patients who could be determined
ineligible by record review, and reduces the volume of
patients to be approached for interest and screening. After
review of the EMR, a list of patients who remain eligible
for the study is prepared for each unit.
Screening
According to VAPHS IRB regulations, patients may not
be directly approached about research participation by
individuals who are not directly associated with the
patient’s care; a clinical care provider must first secure
permission for a member of the research staff to ap-
proach the patient. For this reason, our study’s Research
Assistant (RA) first visits each of the three participating
units and presents the charge nurse with the list of the
prescreened patients admitted to that unit. The charge
nurse (or delegate) then approaches each patient on the
list to request his/her permission to allow the RA to
approach the patient (i.e., enter the room to provide a
study overview and begin the recruitment process). The
RA then provides the patient with a general description
of the study. If interested, the patient is asked to provide
verbal consent for eligibility screening, which is performed
by the RA. In Table 2, the four-step study screening
process is represented by the “Eligibility Screening (ES)”
column for each study arm.
Because hospitalized individuals may have altered
mental status due to acute illness or receipt of sedating
medication, the Short Blessed Test (SBT) is first per-
formed to assess for cognitive impairment. The SBT is a
Figure 1 Study design and procedures.
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deficits in orientation, registration, and attention [27].
Patients are then assessed for hazardous alcohol con-
sumption using criteria from the U.S. National Institute
on Alcohol Abuse and Alcoholism (NIAAA). Individuals
who consume more than 14 drinks/week or 4 drinks/oc-
casion (men); or more than 7 drinks/week or 3 drinks/
occasion (women) are considered hazardous drinkers
[2]. Number of drinks consumed per week is determined
by the product of responses to the following two ques-
tions: (1) On average, how many days a week do you
have an alcoholic drink? and (2) On a typical drinking
day, how many standard-sized drinks do you have? [28].
A “standard-sized drink” refers to 12 ounces of beer, 5
ounces of wine, or 1.5 ounces of liquor/spirits [2]. Number
of binge drinking episodes is assessed through a third
question: How many times in the past 30 days have youhad 5 or more standard-sized drinks in a day (men), or 4
or more standard-sized drinks in a day? (women) [2]. The
use of NIAAA criteria to determine the need for an alco-
hol BI provides us with precise quantification of alcohol
use for measurement of our primary outcome (number of
drinks/week) and is consistent with VA/Department of
Defense Clinical Practice Guidelines, which recommend
BI for individuals who drink above the specified limits or
who drink despite contraindications [28].
Potential participants also complete the Alcohol Use
Disorders Identification Test – Consumption (AUDIT-C)
to provide an additional alcohol outcome measure that is
consistent with and easily comparable to clinical practice in
VA primary care and TJC measure specifications. The
AUDIT-C is a widely used and validated three-item alcohol
screen that can help identify persons who are hazardous
drinkers. The AUDIT-C is scored on a scale of 0–12. For
Table 2 Study assessments by study arm and timepoint
Arm 1 brief
intervention (BI)
Arm 2 attention
control (AC)
Arm 3 attention
control, limited
assessment (AC-LA)
Timepoint Timepoint Timepoint
Variable Instrument ES PC B FU ES PC B FU ES PC B FU
Cognitive status Short Blessed Test X X X
Alcohol screening status AUDIT-C X X X X X X
Drinks per week and Binge episodes last 30 days 3 NIAAA questions X X X X X X
Alcohol dependence Modified CIDI-SAM X X X
Sociodemographic/ clinical data Sociodemographic form X X X X X X
Readiness to change drinking behavior and
adverse consequences of alcohol use
Single items from SOCRATES
and SIP-2R
X
Readiness to change drinking behavior SOCRATES X X X X X
Adverse consequences of alcohol use SIP-2R X X X X X
Participant responsiveness (patient opinions
about the intervention)
4-item investigator developed
instrument
X
Note: AUDIT-C = Alcohol Use Disorders Identification Test, Consumption; NIAAA = National Institute on Alcohol Abuse and Alcoholism; SOCRATES = Stages of
Change Readiness and Treatment Eagerness Scale; SIP-2R = Short Inventory of Problems; Timepoints – ES = Eligibility Screening (10–25 minutes); PC = Post
Consent (5 minutes); B = Baseline (10 minutes); FU = Follow-up at 6 months (30–45 minutes).
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women, scores of 3 or more are considered positive [29,30].
Section C (Alcohol) from the Composite International
Diagnostic Interview, Substance Abuse Module (CIDI-
SAM) [31] is administered to rule out hazardous
drinkers who also meet criteria for alcohol dependence
(Table 2). The CIDI-SAM is a comprehensive, fully
structured diagnostic interview for the assessment of
mental disorders that provides, by means of algorithms,
lifetime and current diagnoses according to the ac-
cepted definitions of ICD-10 and the Diagnostic and
Statistical Manual of Mental Disorders, Fourth Edition
(DSM-IV) [31,32]. Section C of the CIDI-SAM can be
administered by trained clinician or nonclinician inter-
viewers in approximately 15 minutes in general popula-
tions outside of psychiatric treatment settings [31]. In
partnership with the instrument developers, we modi-
fied Section C of the CIDI-SAM to facilitate its use in
the specific context of this research study (for the rapid
identification of potential alcohol dependence to deter-
mine study eligibility). All staff were trained by the in-
strument developers to administer this modified
instrument, which contained items C16–C18, C20,
C25–C30, C33, and CARD 7 of the original CIDI-SAM.
Hazardous drinkers who do not meet criteria for alcohol
dependence according to CIDI-SAM are eligible for study
participation. Eligible individuals then complete the
informed consent process with the RA. While the RA
then determines the patient’s randomization assignment,
each patient completes a basic investigator-developed
sociodemographic and clinical information form. General
health behavior questions extracted directly from the Be-
havioral Risk Factor Surveillance System questionnaire areembedded within the sociodemographic form to assess
other health behaviors such as tobacco use, physical
activity, and diet [31,33].
Randomization
Participants are randomized to one of the three study
conditions (arms) described below. Randomization assign-
ments were generated by the study statistician prior to
study start and placed in masked envelopes. Randomization
sequences were stratified by sex, race, and hospital unit
in a 2:1:1 ratio. This unequal allocation to the three
study conditions allows more veterans to be exposed to
the expected efficacious intervention and more obser-
vations to be available for analyses of mediators and
moderators of positive outcomes in the BI group.
Arm 1: Brief intervention
Arm 1 comprises the experimental BI condition (Table 3).
The three-part BI is adapted from the Brief Negotiated
Interview [34] and supplemented with alcohol-related pa-
tient education materials available through the VA [35,36]
and NIAAA [37]. Part I, the core BI, consists of a multi-
component motivational discussion with the nurse inter-
ventionist within 12 hours of baseline assessment, which
includes personalized risk feedback, advice to abstain or
reduce consumption, and the negotiation of an individual
change plan [28,34,38,39]. Part II consists of a single, brief,
in-hospital or telephone follow-up session, with the same
nurse interventionist, to briefly reinforce the original inter-
vention, discuss and “troubleshoot” the patient’s change
plan, and offer additional encouragement. Part III of the
intervention consists of a brief follow-up telephone call
2 weeks following hospital discharge, during which the
Table 3 Components of 3-part brief intervention for
hospitalized hazardous drinkers
Part I: Core brief intervention (~15 minutes) [28,34,38,39]
● Expression of concern about the patient’s level of alcohol
consumption
● Personalized feedback linking alcohol use and health
● Linkage of alcohol to admitting diagnosis, if applicable
● Advice to abstain/reduce alcohol consumption to below NIAAA
limits
● Assessment of motivation/readiness to change drinking behavior
● Support for choosing an alcohol consumption goal
● Strategies/encouragement for reaching alcohol consumption goal
(change plan)
● Potential referral to specialty care or additional support
Part II: In-hospital follow-up session (12–24 hours after core brief
intervention, ~15 minutes)
● Basic reinforcement of core brief intervention
● Re-assessment and support of motivation and review of change plan
(if applicable)
● Discussion of challenges/barriers to change
● Consideration of additional strategies for change plan
● Support and encouragement for reaching goal
Part III: Telephone follow-up session (2 weeks post-initial brief
intervention, ~15 minutes)
● Same as part II
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original intervention, discusses the patient’s change
plan, and offers additional encouragement (Table 3).
Typical BI follow-up periods for hospitalized patients
range from one week (for written materials) to one month
(for additional intervention) [12,40]. We selected a 2-week
period in order to verbally reinforce recent intervention
material, while allowing recently hospitalized patients time
to readjust and resume self-care practices. For patients
who do not initially establish an alcohol consumption goal
or initiate a change plan during the initial BI, the follow-
up session focuses on exploring and supporting general
readiness to change.
Arms 2 & 3: Control conditions
Arm 2 (AC) and Arm 3 (AC-LA) comprise the control
conditions. Patients in Arms 2 and 3 receive healthy
lifestyle brochures that address general healthy lifestyle
behaviors such as dietary recommendations, tobacco
cessation, and weight management. Brochures were de-
liberately selected that do not contain content similar
to that of the alcohol BI. To ensure parallel attention
and number of contacts across groups [41], patients in
Arms 2 and 3 also receive a 5–15 minute follow-up
telephone call at 2 weeks post-discharge to inquire about
general well-being and to review brochure content. Arms2 and 3 serve as “usual care” insofar as alcohol screening
or intervention for hazardous drinking is not routine
standard of care for hospitalized patients at this VA
medical center.
Baseline assessment
The extent of patients’ baseline assessments depends on
their randomization assignment (Table 2). As previously
mentioned, all alcohol consumption data related to the
primary outcomes are gathered by the RA during eligibil-
ity screening. All sociodemographic/clinical data are gath-
ered immediately prior to randomization. Participants in
Arms 1 and 2 are administered the Stages of Change
Readiness and Treatment Eagerness Scale (SOCRATES)
and the Short Inventory of Problems (SIP-2R) instruments
by the RA. The SOCRATES, Version 8, is a 19-item in-
strument with three subscales: Recognition (of a potential
alcohol problem), Ambivalence (about one’s drinking),
and Taking Steps (towards behavior change) [42]. Norma-
tive data are available to aid in subscale score interpret-
ation. We assess adverse consequences of alcohol use with
the SIP-2R, a widely used 15-item, standalone, short ver-
sion of the Drinker Inventory of Consequences scale [43].
This instrument assesses adverse consequences of alcohol
use over the past 3 months in five areas: interpersonal,
physical, social, impulsive, and intrapersonal [43]. The
SOCRATES and SIP-2R instruments are not administered
to Arm 3 participants to reduce the possible impact of
AR. Patients randomized to the Arm 3 condition receive
only two single items from the SOCRATES and SIP-2R
questionnaires that are embedded within the demographic/
clinical questionnaire for all participants; this allows for a
coarse measure of these constructs in Arm 3 patients.
Follow-up assessment at 6 months
At 6 months post-discharge, all participants receive the
following assessments from the RA by telephone: the
sociodemographic questionnaire with embedded general
health questions; the AUDIT-C; NIAAA questions re-
garding the number of drinks consumed per week and
number of binge drinking episodes in the past 30 days;
the SOCRATES; and the SIP-2R (see follow-up column,
Table 2).
Assessment of intervention fidelity (Specific aim 2)
We are assessing the five classic components of inter-
vention fidelity: quality of delivery, exposure, adherence,
participant responsiveness, and program differentiation
[44]. These components are defined as follows: (1) qual-
ity of delivery: the extent to which all six FRAMES
counseling components (feedback, responsibility, advice
to change, menu of options, empathy, self-efficacy) [45]
and three specific motivational interviewing (MI) tech-
niques (reflective listening, decisional balance, assessment
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exposure: the duration of the intervention (minutes);
(3) adherence: the number and character of procedural
deviations and interruptions to intervention delivery;
(4) participant responsiveness: patient opinions about
the intervention; and (5) program differentiation: the
extent to which only the BI group receives alcohol-
related feedback and counseling (i.e., avoiding “cross-
contamination” across conditions).
Intervention fidelity is assessed for Parts I and II of
the intervention using several data collection methods.
First, we are audio recording 100 percent of the Part I
interventions. The Study Coordinator will review 50 per-
cent of the audio recordings (randomly selected and
stratified by unit over time) to assess quality of delivery,
exposure, and adherence. Barriers to intervention fidelity
are assessed using several data collection methods. First,
the nurse interventionist maintains narrative field notes
on each intervention session, focusing on facilitators and
barriers to intervention delivery and patient response to
the intervention. Quality of delivery is rated using modified
versions of established checklists for BI, which are based on
the FRAMES model and principles of MI [45-47], upon
which BI is based. For the recorded interventions and
follow-up calls, we compare the interventionist’s notes to
the content of the phone calls. Participant responsiveness is
assessed at the conclusion of each intervention. Participants
indicate their level of agreement with four statements
addressing perceptions of the intervention (e.g., helpfulness,
supportiveness) using a 7-point Likert-style scale, and
briefly explain each answer in a free-text format below each
item. Program differentiation is assessed by asking all
groups at the 2-week follow-up call and the 6-month
timepoint to recall the extent to which they received
any additional alcohol-related feedback, recommendations,
or counseling (e.g., primary care provider). These questions
are embedded in the sociodemographic/clinical form.
Nurse interventionist training
Prior to the study, the nurse interventionist, a member
of the research team, received a 2-day intensive MI
training led by certified trainers from the Motivational
Interviewing Network of Trainers [48]. The Principal In-
vestigator provided additional training over the course of
one month that was specific to the use of BI techniques.
This training included additional role-plays featuring in-
patient care scenarios with staff serving as “standardized
patients”, as well as training DVDs and webinars demon-
strating effective BI patient interactions.
Analysis plan
For Specific Aim 1, data analysis will focus on the
change in alcohol consumption variables from baseline
to 6 months across the three arms and, to the extentpossible, exploratory analyses of moderators and media-
tors of the observed effects. The primary independent
variable is the randomized treatment group. The primary
outcomes of interest are: alcohol screening status, num-
ber of drinks/week (past 30 days), and number of binge
drinking episodes (past 30 days). Additional outcomes
include readiness to change drinking behavior and number
of adverse consequences of alcohol use (for patients in
Arms 1 and 2 only). Specific Aim 1 will be tested with
mixed-effects regression models that account for within-
patient correlation and clustering of patients within medical
units. To further elucidate the impact of BI on the out-
comes of interest, additional post-hoc tests for all pair-wise
comparisons (i.e., BI vs. AC, BI vs. AC-LA, AC vs. AC-LA)
will be conducted.
To the extent possible, we will also conduct explora-
tory analyses of potential moderators and mediators of
effects due to the intervention. Comparisons between
Arm 1 and Arm 2 can include more variables related to
the underlying positive changes that BI is designed to fa-
cilitate. In particular, we will be able to explore whether
the baseline SOCRATES and SIP are important modera-
tors of change in drinking behaviors, in addition to the
demographic moderators.
A sample size of 320 that complete the study (160 BI,
80 Attention Control, 80 Attention Control, Limited As-
sessment) will allow us to detect mean differences of 2.6
drinks per week and 0.34 points on the AUDIT-C. Sam-
ple size estimates included expected accrual of veteran
inpatients into the study, duration of study participation
(6 months), and number of patients expected to be lost
to follow-up based on previous BI studies of hospitalized
patients (20–30%) [12,14,16,40].
To characterize barriers to intervention fidelity (Specific
Aim 2), we will use basic descriptive statistics (e.g., fre-
quency counts, means, medians) to describe the numbers
of deviations and interruptions to intervention delivery as
planned. Based on the interventionist field notes, we will
categorize the types of deviations/interruptions. We will
also use these descriptive statistics to describe duration of
the intervention (in minutes), the presence/absence of
each FRAMES and MI technique within the intervention,
and the receipt/nonreceipt of additional alcohol feedback,
advice, or counseling. We will also categorize the types of
additional feedback/counseling received, the provider in-
volved, and the context in which it occurred. Participant
responsiveness data (opinions about the intervention) will
be analyzed with frequency counts and simple content
analysis of free-text comments.
Additionally, to characterize eligibility, recruitment,
and retention of participants, we will develop a recruit-
ment funnel to assess: (a) rates of patient eligibility
among hospitalized veterans; (b) rates of refusal for
screening; and (c) rates of refusal for study enrollment.
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attempts to contact participants at 2 weeks and 6 months;
and the (e) proportion of successful to unsuccessful
telephone contacts at 2 weeks and 6 months. We will
also categorize and generate frequency counts of reasons
for: (f) patient ineligibility; (g) screening refusal, and (h)
enrollment refusal.
Discussion
Hospitalization can be a window of opportunity in which
to engage the patient who is drinking at hazardous levels
in a BI discussion, linking alcohol use to acute/chronic
health problems, and then assessing and supporting per-
sonal motivation to change drinking behavior, particularly if
the hospital admission is alcohol related. This preventative,
public health-oriented approach is designed to help avert
the physical and psychosocial consequences of hazardous
alcohol consumption for individuals and their families.
Based on this rationale, and on evidence of the efficacy of
BI in other health-care settings, hospital accreditation and
quality assurance bodies in the United States have issued
and endorsed performance measures pertaining to alcohol
BI for hospitalized patients.
Several features of our trial represent improvements in
study design over other BI trials, particularly those with
inpatients; these features are discussed in the following
sections.
Attention to potential AR
Our three-arm design allows us to compare the effect of
the intervention with that of usual care in the presence
or absence of extensive alcohol-related assessment. Un-
equal changes in the primary dependent variables (number
of drinks/week, number of binge drinking episodes, change
in alcohol screening status) across the two control groups
will suggest the presence of AR. To further reduce potential
AR, we are limiting the number, scope, and frequency of
assessments [21]. We are using only one instrument each
for two of the five dependent variables and are limiting the
assessment of alcohol use/hazardous drinking to six items.
Also, to minimize AR, we have only one assessment time-
point following baseline. Additionally, normative feedback
about drinking behavior to both control group participants
is provided within the context of general health mainten-
ance recommendations [21].
Assessment of intervention fidelity
Assessment of intervention fidelity focuses on factors
that impede delivery of the intervention and avoid inter-
ventionist drift. In our prior work, inpatient nurses iden-
tified numerous factors that could affect intervention
fidelity and feasibility (e.g., time, potential interruptions
for clinical care, and patient privacy and engagement)
[49]. Features of acute care delivery and the inpatientsetting, such as frequent need for clinical care/testing
and shared patient rooms, may significantly impede BI
delivery and compromise intervention integrity [50].
Only one other BI study among hospitalized patients
has reported efforts to ensure intervention fidelity [12].
Other negative trials either explicitly report difficulties
ensuring intervention fidelity (e.g., intervention duration,
techniques) [14], or do not report on intervention fidelity
at all [15,16].
Limitation of the entire sample to hazardous,
nondependent drinkers
Hazardous, nondependent drinkers are the population
for whom BI was intended and in whom it has the greatest
demonstrated efficacy [51,52]. Individuals with alcohol de-
pendence typically require treatment of greater intensity
and duration than BI provides, and particular attention to
issues of loss of control, tolerance, and withdrawal. Other
(null) trials of BI for hospitalized patients have included
heavier-drinking and/or dependent individuals [12,14,19].
However, as noted earlier, in one case, when the sample
was later restricted to hazardous, nondependent users,
effects for reduced alcohol consumption were in fact
detected [13]. We consider inclusion of only hazardous
drinkers in the sample to be a strength because it elimi-
nates the potential “noise” (and null effects) caused by
including individuals in the sample for whom BI is not
intended.
This study is not designed to answer questions of BI’s
efficacy in other groups of drinkers (e.g., dependent indi-
viduals), where evidence for the efficacy of BI is uncer-
tain [51,53]. Nonetheless, we recognize the fact that TJC
measures do require BI for all patients with a positive
alcohol screening (thus potentially requiring BI for
patients who also meet criteria for alcohol dependence).
Our study results will not be able to address the efficacy
of BI for individuals with an alcohol use disorder.
Patient-level randomization and unequal allocation of
patients to groups in a 2:1:1 ratio
This aspect of study design allows more veterans to be
exposed to the expected efficacious intervention and
permits a more economically feasible study, because
fewer hospital units will be needed than with cluster
randomization. Also, each hospital unit has its own
unique staff, administration, and culture that could in-
fluence the delivery and efficacy of the BI. With our
design, unit characteristics are equally distributed
across participants.
A three-part BI discussion that includes two follow-up
sessions
Follow-up sessions have been recommended by other re-
searchers to increase the effect and salience of the BI
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patient BI with ongoing attention to hazardous alcohol
use in primary care, post-discharge.
Additional considerations
As our overarching goal is to inform the debate about
the efficacy of alcohol BI for hospitalized individuals in
the context of imminent widespread adoption of TJC
hospital performance measures, this study was not de-
signed as an effectiveness trial that mirrors the measures’
current “real-life” specifications, particularly since such
measures are subject to modification by TJC as well as
VA’s own External Peer Review Program. Nonetheless, we
recognize that our use of the NIAAA questions to deter-
mine study eligibility/need for a BI is slightly different
from what is specified in the measures from TJC. Specific-
ally, TJC measures dictate that individuals be screened
using a validated screening instrument (such as the
AUDIT-C) and that individuals with a positive alcohol
screen must then receive a BI [4]. Additional assessment
of alcohol consumption is not required to make the deter-
mination of need for a BI. In contrast, in the VA Substance
Use Disorder Clinical Practice Guidelines, the need for BI
is not determined by screening result, but by the results of
“additional assessment” (i.e., determination of whether the
patient is drinking above the NIAAA limits or drinking
despite contraindications) [28].
We nonetheless anticipate that the applicability of our
results from this trial will not be severely hampered by
these differences in use of the NIAAA questions versus
AUDIT-C to determine need for BI. If our study ultimately
demonstrates the efficacy of BI for reducing drinking in
hospitalized patients, then one could argue that we have
generated evidence for the efficacy of BI in a “more severe”
patient population of drinkers (i.e., those who exceed the
NIAAA limits) and that its efficacy in a “less severe” group
(i.e., those who “only” had a positive AUDIT-C screen)
would still be in question. However, this assertion would
be valid only if the AUDIT-C has a high rate of false nega-
tives (i.e., patients who score negative on the AUDIT-C
despite drinking above the NIAAA-specified limits).
Importantly, in one recent study of almost 500,000
individuals, only about five percent of men and three
percent of women in the study had negative AUDIT-C
screens, despite reported heavy episodic drinking (i.e.,
drinking above daily limits) [54].
Conclusion
The results of this trial will provide greater justification
for or against the use of BI performance measures in the
inpatient setting, as well as help inform organizational
responses to BI-related hospital accreditation and per-
formance measures from TJC and other entities interested
in quality of care. Our intervention fidelity and executiondata can also inform the specifications of such measures
and their implementation. Administrators and clinicians
charged with alcohol-related performance measurement
and corresponding BI implementation will require effica-
cious, practical, and patient-centered BI delivery models.
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